Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma

Jae Cheol Jo, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan Sik Park, Jooryung Huh, Sang Wook Lee, Jin Sook Ryu, Cheolwon Suh

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences